Skip to main content

The Evidence on Ozempic to Treat Addiction

Healthcare
United States
Started February 21, 2026

Dhruv Khullar on the latest research on GLP-1 drugs, which, though typically used to manage diabetes and obesity, are showing promise as groundbreaking treatments for addictions of all kinds

Source Articles

🗳️ Join the conversation
5 statements to vote on • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (7+ recommended) 5/7
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM Posted by will Feb 21, 2026
Relying on medications like Ozempic for addiction might undermine the importance of traditional therapies and holistic treatment approaches.
0 total votes
CLAIM Posted by will Feb 21, 2026
While Ozempic shows promise, more research is needed to fully understand its long-term effects on addiction treatment.
0 total votes
CLAIM Posted by will Feb 21, 2026
Using Ozempic for addiction raises ethical concerns about medicalizing behaviors and the implications for personal responsibility.
0 total votes
CLAIM Posted by will Feb 21, 2026
The potential of GLP-1 drugs in addiction treatment could lead to a paradigm shift in how we address substance use disorders.
0 total votes
CLAIM Posted by will Feb 21, 2026
GLP-1 drugs like Ozempic offer a revolutionary approach to treating addiction, potentially reducing cravings and improving recovery outcomes.
0 total votes

💡 How This Works

  • Add Statements: Post claims or questions (10-500 characters)
  • Vote: Agree, Disagree, or Unsure on each statement
  • Respond: Add detailed pro/con responses with evidence
  • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us